|
GB2434312B
(en)
|
2006-01-18 |
2011-06-29 |
Gw Pharma Ltd |
Cannabinoid-containing plant extracts as neuroprotective agents
|
|
GB2450753B
(en)
*
|
2007-07-06 |
2012-07-18 |
Gw Pharma Ltd |
New Pharmaceutical formulation
|
|
GB2451254A
(en)
*
|
2007-07-24 |
2009-01-28 |
Gw Pharma Ltd |
Cannabidiol for use in the treatment of neurodegenerative conditions
|
|
WO2010012506A1
(en)
*
|
2008-07-31 |
2010-02-04 |
Bionorica Research Gmbh |
Cannabinoids for use in treating or preventing cognitive impairment and dementia
|
|
GB2471523A
(en)
|
2009-07-03 |
2011-01-05 |
Gw Pharma Ltd |
Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
|
|
GB2478595B
(en)
*
|
2010-03-12 |
2018-04-04 |
Gw Pharma Ltd |
Phytocannabinoids in the treatment of glioma
|
|
GB2479153B
(en)
*
|
2010-03-30 |
2014-03-19 |
Gw Pharma Ltd |
The phytocannabinoid cannabidivarin (CBDV) for use in the treatment of epilepsy
|
|
TWI583374B
(zh)
*
|
2010-03-30 |
2017-05-21 |
Ｇｗ伐瑪有限公司 |
使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
|
|
GB2487183B
(en)
*
|
2011-01-04 |
2018-10-03 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
|
|
US8445034B1
(en)
|
2010-11-02 |
2013-05-21 |
Albert L Coles, Jr. |
Systems and methods for producing organic cannabis tincture
|
|
GB2487712B
(en)
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
GB201111261D0
(en)
|
2011-07-01 |
2011-08-17 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
|
|
GB2495118B
(en)
*
|
2011-09-29 |
2016-05-18 |
Otsuka Pharma Co Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
GB2504263B
(en)
|
2012-06-08 |
2015-09-16 |
Gw Pharma Ltd |
Synergistic therapies for neuroprotection
|
|
CA2895805A1
(en)
|
2012-12-18 |
2014-06-26 |
Kotzker Consulting Llc |
Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
|
|
JP6581509B2
(ja)
|
2013-02-28 |
2019-09-25 |
ティーウィノット テクノロジーズ リミテッド |
化合物を合成する化学工学プロセス及び装置
|
|
EP2968259B1
(en)
|
2013-03-14 |
2022-09-14 |
SC Laboratories Inc. |
Bioactive concentrates and uses thereof
|
|
US10774288B2
(en)
|
2013-09-18 |
2020-09-15 |
The Werc Shop, LLC |
Terpene-based compositions, processes, methodologies for creation and products thereby
|
|
US9380813B2
(en)
|
2014-02-11 |
2016-07-05 |
Timothy McCullough |
Drug delivery system and method
|
|
US10821240B2
(en)
|
2014-02-11 |
2020-11-03 |
Vapor Cartridge Technology Llc |
Methods and drug delivery devices using cannabis
|
|
US9220294B2
(en)
|
2014-02-11 |
2015-12-29 |
Timothy McCullough |
Methods and devices using cannabis vapors
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
CA2990071C
(en)
|
2014-07-14 |
2023-01-24 |
Librede Inc. |
Production of cannabigerolic acid
|
|
US11293038B2
(en)
|
2014-07-14 |
2022-04-05 |
Librede Inc. |
Production of cannabinoids in yeast
|
|
AU2015308136B2
(en)
|
2014-08-25 |
2020-07-09 |
Teewinot Technologies Limited |
Apparatus and methods for the simultaneous production of cannabinoid compounds
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531278A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
CA3135893C
(en)
|
2014-10-21 |
2023-11-14 |
United Cannabis Corp. |
Cannabis extracts and methods of preparing and using same
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US9585867B2
(en)
|
2015-08-06 |
2017-03-07 |
Charles Everett Ankner |
Cannabinod formulation for the sedation of a human or animal
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
MX2018004632A
(es)
*
|
2015-10-16 |
2018-11-09 |
Scythian Biosciences Inc |
Metodos y composiciones para el tratamiento de una lesion cerebral traumatica.
|
|
WO2017093986A1
(en)
*
|
2015-12-05 |
2017-06-08 |
Canabuzz-Med |
Veterinary composition and methods for production and use
|
|
US11191794B1
(en)
|
2016-02-08 |
2021-12-07 |
Jeff Nordahl |
Packaged hemp products formed from raw cannabis
|
|
US9955716B1
(en)
|
2016-02-08 |
2018-05-01 |
Jeff Nordahl |
Packaged frozen ice pops of cannabis juice purée
|
|
US11172698B1
(en)
|
2016-02-08 |
2021-11-16 |
Jeff Nordahl |
Pasteurized juice formed from raw cannabis
|
|
US11779622B1
(en)
|
2016-02-08 |
2023-10-10 |
Jeff Nordahl |
Packaged raw cannabis powder
|
|
PT3429580T
(pt)
*
|
2016-03-16 |
2025-08-12 |
Buzzelet Development And Technologies Ltd |
Composição de canabinoides enriquecida em terpenos
|
|
GB2548873B
(en)
|
2016-03-31 |
2020-12-02 |
Gw Res Ltd |
Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
|
|
GB2549278B
(en)
*
|
2016-04-11 |
2021-02-17 |
Gw Res Ltd |
Use of cannabidivarin in the treatment of autism spectrum disorder
|
|
GB2549277B
(en)
*
|
2016-04-11 |
2021-02-17 |
Gw Res Ltd |
Cannabidiolic Acid for use in the Treatment of Autism Spectrum Disorder
|
|
US10499584B2
(en)
|
2016-05-27 |
2019-12-10 |
New West Genetics |
Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
|
|
AU2017290107A1
(en)
|
2016-06-29 |
2019-01-17 |
CannScience Innovations Inc. |
Decarboxylated cannabis resins, uses thereof and methods of making same
|
|
US9717683B1
(en)
|
2016-06-29 |
2017-08-01 |
Ep Pharma, Llc |
Low-temperature inhalation administration of cannabinoid entities
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2551986A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Parenteral formulations
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
CA3077624A1
(en)
*
|
2016-10-01 |
2018-04-05 |
James Smeeding |
Pharmaceutical compositions comprising a statin and a cannabinoid and uses thereof
|
|
CN109963595B
(zh)
*
|
2016-10-11 |
2023-02-03 |
Gbs全球生物制药公司 |
用于治疗神经退行性疾病的含有大麻素的复合混合物
|
|
US10239808B1
(en)
*
|
2016-12-07 |
2019-03-26 |
Canopy Holdings, LLC |
Cannabis extracts
|
|
GB2557921A
(en)
|
2016-12-16 |
2018-07-04 |
Gw Res Ltd |
Use of cannabinoids in the treatment of angelman syndrome
|
|
WO2018144637A1
(en)
|
2017-02-01 |
2018-08-09 |
Growblox Life Sciences L.L.C. |
Cannabinoid-containing complex mixtures for the treatment of mast cell-associated or basophil-mediated inflammatory disorders
|
|
CA3053187A1
(en)
*
|
2017-02-09 |
2018-08-16 |
Bodhi Research & Development Inc. |
Cannabinoid-containing fatty acid formulations for treating disorders of the nervous system
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
AU2018239671B2
(en)
|
2017-03-24 |
2024-08-15 |
Trait Biosciences, Inc. |
High level In vivo biosynthesis and isolation of water-soluble cannabinoids in plant systems
|
|
CN107137605A
(zh)
*
|
2017-03-27 |
2017-09-08 |
昭通天麻产业开发有限公司 |
一种由乌天麻提取物和植物大麻提取物及口服载体组成的组合物
|
|
WO2018205038A1
(en)
*
|
2017-05-12 |
2018-11-15 |
Tetra Bio-Pharma Inc. |
Compositions comprising cannabinoids and terpenes useful in the treatment of cancer and vascular ocular disorders via inhibition of hedgehog signalling
|
|
GB2564383B
(en)
|
2017-06-23 |
2021-04-21 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
|
|
EP3730145A1
(en)
|
2017-07-11 |
2020-10-28 |
Trait Biosciences, Inc. |
Generation of water-soluble cannabinoid compounds in yeast and plant cell suspension cultures and compositions of matter
|
|
US11946059B2
(en)
|
2017-07-11 |
2024-04-02 |
Trait Biosciences, Inc. |
In vivo generation of water-soluble cannabinoids in plant cell suspension cultures
|
|
US11905543B2
(en)
|
2017-07-11 |
2024-02-20 |
Trait Biosceinces, Inc. |
In vivo generation of water-soluble acetylated cannabinoid glycoside compounds in plant cell suspension cultures
|
|
GB2564459B
(en)
*
|
2017-07-12 |
2022-03-09 |
Gw Res Ltd |
Use of cannabinoids in the treatment of a neurodegenerative disease or disorder
|
|
US10272360B2
(en)
|
2017-08-05 |
2019-04-30 |
Priya Naturals, Inc. |
Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
|
|
US20200281890A1
(en)
*
|
2017-09-25 |
2020-09-10 |
Canopy Health Innovations |
Compositions comprising cannabidiol, tetrahydrocannabinol, terpenes, and flavonoids and use thereof in the treatment of insomnia
|
|
US20190183849A1
(en)
*
|
2017-10-21 |
2019-06-20 |
Alexander Kariman |
Compound and method for treatment of diseases and disorders
|
|
US10307392B2
(en)
*
|
2017-10-21 |
2019-06-04 |
Alexander Kariman |
Compound and method for treatment of diseases and disorders
|
|
GB2568929A
(en)
|
2017-12-01 |
2019-06-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US10722545B2
(en)
|
2018-01-01 |
2020-07-28 |
Alexander Kariman |
Compound and method for treatment of movement disorders
|
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
|
CA3089994A1
(en)
|
2018-01-31 |
2019-08-08 |
Canopy Holdings, LLC |
Hemp powder
|
|
MX2020010284A
(es)
*
|
2018-03-30 |
2021-02-18 |
India Globalization Capital Inc |
Método y composición para el tratamiento de los trastornos del snc.
|
|
GB201806953D0
(en)
|
2018-04-27 |
2018-06-13 |
Gw Res Ltd |
Cannabidiol Preparations
|
|
US20200035118A1
(en)
|
2018-07-27 |
2020-01-30 |
Joseph Pandolfino |
Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
|
|
US20220304963A1
(en)
*
|
2018-07-27 |
2022-09-29 |
Basil Shaaban |
Composition having an optimized fatty acid excipient profile
|
|
US10897925B2
(en)
|
2018-07-27 |
2021-01-26 |
Joseph Pandolfino |
Articles and formulations for smoking products and vaporizers
|
|
CA3119729A1
(en)
|
2018-10-10 |
2020-04-16 |
Treehouse Biotech, Inc. |
Synthesis of cannabigerol
|
|
MX2021005475A
(es)
*
|
2018-11-09 |
2021-09-08 |
Agriculture Victoria Serv Pty |
Plantas de cannabis con un perfil de cannabinoides enriquecido con ¿-9-tetrahidrocannabinol, cannabigerol y tetrahidrocannabivari na.
|
|
WO2020093170A1
(en)
*
|
2018-11-09 |
2020-05-14 |
Cronos Group Inc. |
Liquid composition for an electronic vapor device
|
|
KR102445087B1
(ko)
|
2019-05-03 |
2022-09-20 |
자이우스 라이프 사이언시스 아이엔씨. |
통증 관리용 제형
|
|
US12220396B2
(en)
|
2019-05-03 |
2025-02-11 |
Zyus Life Sciences Inc. |
Formulation for pain management
|
|
US12178797B2
(en)
|
2019-05-03 |
2024-12-31 |
Zyus Life Sciences Inc. |
Formulation for pain management
|
|
GB2584341B
(en)
|
2019-05-31 |
2023-03-01 |
Gw Res Ltd |
Cannabinoid formulations
|
|
US12557843B2
(en)
*
|
2019-07-15 |
2026-02-24 |
Raymond Louis Larson |
Other than cannabinoids, flavonoids, and terpenes
|
|
MX2022003189A
(es)
|
2019-09-16 |
2022-06-08 |
Vapor Cartridge Tech Llc |
Sistema de administración de fármacos con sustratos apilables.
|
|
EP4037663A1
(en)
|
2019-10-03 |
2022-08-10 |
Starton Therapeutics, Inc. |
Transdermal delivery of dronabinol
|
|
US12409131B2
(en)
|
2019-10-03 |
2025-09-09 |
Pike Therapeutics Usa, Inc. |
Transdermal delivery of dronabinol
|
|
US12186280B2
(en)
|
2019-10-11 |
2025-01-07 |
Pike Therapeutics Inc. |
Pharmaceutical composition and method for treating seizure disorders
|
|
US12016829B2
(en)
|
2019-10-11 |
2024-06-25 |
Pike Therapeutics Inc. |
Pharmaceutical composition and method for treating seizure disorders
|
|
CN114555068A
(zh)
|
2019-10-14 |
2022-05-27 |
长矛治疗股份有限公司1219014 B.C.有限公司 |
大麻二酚的透皮给药
|
|
US12121617B2
(en)
|
2019-10-14 |
2024-10-22 |
Pike Therapeutics Inc. |
Transdermal delivery of cannabidiol
|
|
US12268699B2
(en)
|
2019-10-14 |
2025-04-08 |
Pike Therapeutics Inc. |
Transdermal delivery of tetrahydrocannabinol
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
US20210290564A1
(en)
*
|
2020-03-17 |
2021-09-23 |
Tauriga Sciences Inc. |
Medicated cannabinoid compositions, methods of manufacturing, and methods of treatment
|
|
AU2021258909A1
(en)
|
2020-04-24 |
2022-12-08 |
Zyus Life Sciences Inc. |
Cannabichromene formulation for pain management
|
|
US11160757B1
(en)
|
2020-10-12 |
2021-11-02 |
GW Research Limited |
pH dependent release coated microparticle cannabinoid formulations
|
|
KR20220084761A
(ko)
*
|
2020-12-14 |
2022-06-21 |
강원대학교산학협력단 |
헴프 껍질 추출물을 포함하는 인지기능 개선용 조성물
|
|
CN113368086B
(zh)
*
|
2021-08-11 |
2021-12-03 |
龙麻(上海)医药研发有限责任公司 |
一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用
|
|
JP2025512495A
(ja)
|
2022-04-12 |
2025-04-17 |
シャッケルフォード・ファーマ・インコーポレーテッド |
発作性障害の治療
|
|
EP4568702A1
(en)
|
2022-08-12 |
2025-06-18 |
Jazz Pharmaceuticals Research UK Limited |
Oral solid dosage forms comprising cannabinoids
|
|
US20240261302A1
(en)
*
|
2023-01-04 |
2024-08-08 |
Florascience Inc. |
Methods of treating neurodegenerative diseases or conditions
|
|
WO2025090587A1
(en)
|
2023-10-23 |
2025-05-01 |
Inmed Pharmaceuticals Inc. |
Cannabinoids compounds and their use in the treatment of neuronal disorders
|
|
WO2025172553A1
(en)
|
2024-02-14 |
2025-08-21 |
Jazz Pharmaceuticals Research Uk Limited |
Oral solid dosage forms comprising cannabinoids
|
|
WO2025234537A1
(ko)
*
|
2024-05-07 |
2025-11-13 |
주식회사 퓨처에프바이오텍 |
대마 종자 발효물을 포함하는 비만 또는 인지기능 개선용 조성물
|